Withdrawal of steroids: A randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis

被引：29
|
作者：
Junge, G
Neuhaus, R
Schewior, L
Klupp, J
Guckelberger, O
Langrehr, JM
Tullius, S
Neuhaus, P
机构：
[1] Charite Berlin, Klin Allgemein Viszeral & Transplantat Chirurg, D-13353 Berlin, Germany
[2] Charite Berlin, Med Klin MS Nephrol & Intens Med, D-13353 Berlin, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2005年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.transproceed.2005.03.145
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The aim of this study was to evaluate the success of steroid (PRED) withdrawal due to replacement by mycophenolate mofetil (MMF) in orthotopic liver transplant (OLT) recipients with autoimmune hepatitis (AIH). Thirty patients with AIH > 12 months after OLT randomized to receive either PRED and tacrolimus (TAC) or MMF and TAC were followed for 24 months. Withdrawal of steroids showed no difference regarding graft and patient survival. Also we demonstrated significantly lower glucose levels with lower HbA1c and a reduced need for insulin as well as a significantly lower serum cholesterol in the MMF group. Patients without steroids showed a lower incidence of osteopenia. Maintenance therapy in OLT patients with AIH may be performed safely using MMF instead of prednisone.
引用
收藏
页码：1695 / 1696
页数：2
相关论文
共 50 条
  • [21] Hypogammaglobulinemia in heart transplant recipients treated with tacrolimus, mycophenolate, and prednisone
    Avery, RK
    Mawhorter, SD
    Starling, R
    McCarthy, P
    Smedira, N
    Goormastic, M
    Pelegrin, D
    Majercik, M
    Hobbs, R
    Hoercher, K
    Cook, D
    Young, JB
    TRANSPLANTATION, 1999, 67 (07) : S95 - S95
  • [22] Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Roth, D
    Kupin, W
    Rosen, A
    Olson, L
    Esquenazi, V
    Miller, J
    TRANSPLANTATION, 2002, 73 (07) : 1100 - 1106
  • [23] Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients
    Teebken, OE
    Strüber, M
    Harringer, W
    Pichlmaier, MA
    Haverich, A
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (04) : 1265 - 1268
  • [24] Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study
    Shihab, F. S.
    Lee, S. T.
    Smith, L. D.
    Woodle, E. S.
    Pirsch, J. D.
    Gaber, A. O.
    Henning, A. K.
    Reisfield, R.
    Fitzsimmons, W.
    Holman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (02) : 474 - 484
  • [25] Short course daclizumab with mycophenolate mofetil plus low dose tacrolimus and steroids in orthotopic liver transplant recipients.
    Sievers, TM
    Colquhoun, SD
    Arnaout, WS
    HEPATOLOGY, 2000, 32 (04) : 598A - 598A
  • [26] Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
    Figueras, J
    Bernardos, A
    Prieto, M
    Gómez, M
    Rimola, A
    de Urbina, JO
    Cuervas-Mons, V
    de la Mata, M
    Dominguez-Granados, R
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1511 - 1513
  • [27] Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone
    ter Meulen, CG
    Gregoor, PJHS
    Weimar, W
    Hilbrands, LB
    TRANSPLANT INTERNATIONAL, 2001, 14 (02) : 99 - 102
  • [28] A prospective randomized single-center study of prednisone-free immunosuppression that compares two maintenance combinations: Tacrolimus/Mycophenolate Mofetil versus Tacrolimus/Sirolimus.
    Gallon, LG
    Kaufman, DB
    Leventhal, JR
    Abecassis, M
    Fryer, J
    Koffron, A
    Stuart, FP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 664A - 664A
  • [29] Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
    Ciancio, G
    Miller, A
    Burke, GW
    Gharagozloo, H
    Rosen, A
    Roth, D
    Kupin, W
    Pinna, A
    Cespedes, M
    Esquenazi, V
    Miller, J
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1013 - 1014
  • [30] Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus
    Chatur, N
    Ramji, A
    Bain, VG
    Ma, MM
    Marotta, PJ
    Ghent, CN
    Lilly, LB
    Heathcote, EJ
    Deschenes, M
    Lee, SS
    Steinbrecher, UP
    Yoshida, EM
    LIVER INTERNATIONAL, 2005, 25 (04) : 723 - 727
12345